437 related articles for article (PubMed ID: 21154264)
1. Application of Cardio-O-Fix occluders for transcatheter closure of patent ductus arteriosus and interatrial communications: Preliminary experience.
Białkowski J; Szkutnik M; Fiszer R; Głowacki J; Banaszak P; Zembala M
Cardiol J; 2010; 17(6):607-11. PubMed ID: 21154264
[TBL] [Abstract][Full Text] [Related]
2. Preliminary experience in the use of CERA occluders for closure of different intracardiac and extracardiac shunts.
Fiszer R; Szkutnik M; Chodor B; Bialkowski J
J Invasive Cardiol; 2014 Aug; 26(8):385-8. PubMed ID: 25091098
[TBL] [Abstract][Full Text] [Related]
3. Self-expanding nanoplatinum-coated nitinol devices for atrial septal defect and patent ductus arteriosus closure: a swine model.
Lertsapcharoen P; Khongphatthanayothin A; La-orkhun V; Supachokchaiwattana P; Charoonrut P
Indian Heart J; 2006; 58(4):315-20. PubMed ID: 19039147
[TBL] [Abstract][Full Text] [Related]
4. Cardi-O-Fix duct occluder versus Amplatzer duct occluder for closure of patent ductus arteriosus.
Celebi A; Demir IH; Saritaş T; Dedeoğlu R; Yucel IK; Demir F; Erdem A
Catheter Cardiovasc Interv; 2013 Nov; 82(6):961-7. PubMed ID: 23592558
[TBL] [Abstract][Full Text] [Related]
5. The new Occlutech(®) patent ductus arteriosus occluder: Single centre experience.
Boudjemline Y
Arch Cardiovasc Dis; 2016; 109(6-7):384-9. PubMed ID: 26988839
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results.
Aytemir K; Oto A; Özkutlu S; Canpolat U; Kaya EB; Yorgun H; Şahiner L; Sunman H; Ateş AH; Kabakçı G
Congenit Heart Dis; 2013; 8(5):418-27. PubMed ID: 23601507
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter closure of secundum atrial septal defects, a ventricular septal defect, and a patent arterial duct.
Bilgiç A; Celiker A; Ozkutlu S; Ayabakan C; Karagöz T; Ocal T
Turk J Pediatr; 2001; 43(1):12-8. PubMed ID: 11297152
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous closure of multiple atrial septal defects and patent ductus arteriosus during the same session.
Odemiş E; Ozyılmaz I; Güzeltaş A
Turk Kardiyol Dern Ars; 2012 Dec; 40(8):726-8. PubMed ID: 23518889
[TBL] [Abstract][Full Text] [Related]
9. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
Luna M; Banerjee S; Brilakis ES
Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size-ADOIIAS.
Morville P; Akhavi A
Catheter Cardiovasc Interv; 2017 Oct; 90(4):612-617. PubMed ID: 28471089
[TBL] [Abstract][Full Text] [Related]
11. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
Aral M; Mullen M
Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
[TBL] [Abstract][Full Text] [Related]
12. Defect closure in the lipomatous hypertrophied atrial septum with the Amplatzer muscular ventricular septal defect closure device: a case series.
Lin CH; Balzer DT; Lasala JM
Catheter Cardiovasc Interv; 2011 Jul; 78(1):102-7. PubMed ID: 21416575
[TBL] [Abstract][Full Text] [Related]
13. Effect of percutaneous atrial septal defect and patent foramen ovale device closure on degree of aortic regurgitation.
Loar RW; Johnson JN; Cabalka AK; Cetta F; Hagler DJ; Eidem BW; Taggart NW
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1234-7. PubMed ID: 23239614
[TBL] [Abstract][Full Text] [Related]
14. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
Manolis AS
Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
[TBL] [Abstract][Full Text] [Related]
15. Long-term transesophageal echocardiography after patent foramen ovale closure by BioSTAR and Amplatzer patent foramen ovale occluders.
Suligoj NC; Rojko M; Suligoj B; Zorc M; Kar S; Noc M
Catheter Cardiovasc Interv; 2020 Feb; 95(3):349-354. PubMed ID: 31131978
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous closure of patent ductus arteriosus in children using amplatzer duct occluder II: relationship between PDA type and risk of device protrusion into the descending aorta.
Masri S; El Rassi I; Arabi M; Tabbakh A; Bitar F
Catheter Cardiovasc Interv; 2015 Aug; 86(2):E66-72. PubMed ID: 26032159
[TBL] [Abstract][Full Text] [Related]
17. Multicenter nit-occlud® PDA-R patent. Ductus arteriosus occlusion device trial: initial and six-month results.
Granja MA; Trentacoste L; Rivarola M; Barbosa JD; Lucini V; Peirone A; Spillman A
Catheter Cardiovasc Interv; 2015 Aug; 86(2):258-63. PubMed ID: 23460494
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the results of transcatheter closure of patent ductus arteriosus with newer Amplatzer devices.
Liddy S; Oslizlok P; Walsh KP
Catheter Cardiovasc Interv; 2013 Aug; 82(2):253-9. PubMed ID: 23427043
[TBL] [Abstract][Full Text] [Related]
19. The Occlutech Figulla PFO and ASD occluder: a new nitinol wire mesh device for closure of atrial septal defects.
Krizanic F; Sievert H; Pfeiffer D; Konorza T; Ferrari M; Hijazi Z; Jung C; Lauten A; Figulla HR
J Invasive Cardiol; 2010 Apr; 22(4):182-7. PubMed ID: 20351390
[TBL] [Abstract][Full Text] [Related]
20. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.
Steinberg DH; Bertog SC; Momberger J; Franke J; Hofmann I; Renkhoff K; Joy S; Vaskelyte L; Sievert H
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1262-7. PubMed ID: 24948394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
